BPC-157/TB-500 20 mg Blend
- Active Substance: Thymosin beta 4 / Pentadecapeptide (10 mg BPC-157 + 10 mg TB-500)
- Concentration: 20 mg per vial (10 mg each peptide)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Molecular Formula (BPC-157): C62H98N16O22
- Molecular Weight (BPC-157): 1419.54 g/mol
- Sequence (BPC-157): Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Pro-Pro-Ala-Glu-Gly-Lys
- Molecular Formula (TB-500): C38H68N10O14
- Molecular Weight (TB-500): 889.01 g/mol
- Sequence (TB-500): Ac-LKKTETQ
- Synonyms: BPC-157 (Body Protection Compound-157), TB-500 (Thymosin Beta-4 fragment)
BPC-157/TB-500 20 mg – Unleash a Cascade of Regeneration
Product Summary
Envision a research horizon where damaged tissues mend rapidly, and inflammation is subdued with precision. BPC-157/TB-500 20 mg vial from Peptide Sciences USA combines two powerhouse peptides—BPC-157 and TB-500—at a higher potency to amplify tissue repair, accelerate recovery, and combat inflammation. This elite blend is a beacon for researchers seeking to redefine regenerative science with cutting-edge peptide technology.
How BPC-157/TB-500 Blend Works
The BPC-157/TB-500 20 mg blend unites Body Protection Compound-157 (BPC-157), a pentadecapeptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Pro-Pro-Ala-Glu-Gly-Lys, and TB-500, a Thymosin Beta-4 fragment with the sequence Ac-LKKTETQ. BPC-157 drives angiogenesis by upregulating vascular endothelial growth factor (VEGF), enhancing blood flow to injury sites, and promotes collagen synthesis via Akt and ERK pathways. TB-500 regulates actin polymerization, facilitating cell migration and tissue restructuring by modulating microRNA-146a, which suppresses inflammatory cytokines like IL-1 and TRAF6.
Together, this blend creates a synergistic effect: BPC-157 lays the foundation for tissue regeneration, while TB-500 orchestrates cellular movement to rebuild structural integrity. Preclinical studies show BPC-157 reduces tendon healing time by 30–50% in rats, and TB-500 enhances wound closure in pressure ulcer models. Combined, they can accelerate recovery by up to 40% in animal models, making this high-potency blend ideal for researching complex injuries, joint repair, and chronic inflammation.
Why Choose BPC-157/TB-500 20 mg?
The BPC-157/TB-500 20 mg blend is a vanguard in regenerative research, offering amplified benefits for transformative studies. Here's why it stands out:
- Potent Synergy: Combines BPC-157's angiogenesis and TB-500's cell migration to accelerate tissue repair by up to 40% in preclinical models.
- Inflammation Control: Suppresses proinflammatory cytokines, reducing swelling and pain in models of arthritis and gastrointestinal disorders.
- Comprehensive Recovery: Supports healing across muscles, tendons, ligaments, nerves, and mucosal tissues, broadening research applications.
- Enhanced Potency: Higher 20 mg concentration (10 mg each peptide) offers robust dosing flexibility for advanced research protocols.
- Premier Quality: Peptide Sciences USA guarantees 99% purity through advanced synthesis, ensuring consistent research outcomes.
BPC-157/TB-500 20 mg empowers researchers to unleash a cascade of regeneration, backed by the prestige of cutting-edge peptide science.
Product Specifications
Peptide Sciences USA's BPC-157/TB-500 20 mg vial is engineered for excellence in regenerative research, delivering unmatched quality. Here's the breakdown:
- Composition: Contains 20 mg total (10 mg BPC-157, C62H98N16O22, 1419.54 g/mol; 10 mg TB-500, C38H68N10O14, 889.01 g/mol).
- Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous or intramuscular injection.
- Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by High-Performance Liquid Chromatography and Mass Spectrometry.
- Usage Guidelines: Reconstitute with bacteriostatic water and administer subcutaneously or intramuscularly, typically at 1000–2000 mcg daily (500–1000 mcg each peptide) in research protocols. Use under professional supervision.
- Storage: Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.
- Safety: Preclinical studies report minimal side effects, such as mild injection site reactions; limited human data requires research oversight.
This peptide blend is for research purposes only, providing a high-potency platform for studying synergistic healing.
Legal Disclaimer
BPC-157/TB-500 20 mg is supplied for research purposes only and is not FDA-approved for human use. It is not intended to diagnose, treat, cure, or prevent any condition. Consult a licensed professional before use. Peptide Sciences USA assumes no liability for misuse. All information is educational and based on preclinical research.
Frequently Asked Questions
What is the BPC-157/TB-500 20 mg blend used for?
The BPC-157/TB-500 20 mg blend is used in research to explore synergistic tissue repair, inflammation reduction, and recovery in models of muscle, tendon, nerve, and gut injuries.
How does the BPC-157/TB-500 blend promote healing?
BPC-157 stimulates angiogenesis and collagen synthesis, while TB-500 enhances cell migration via actin regulation. Together, they accelerate recovery by up to 40% in preclinical models of soft tissue and joint injuries.
What is the recommended dosing for BPC-157/TB-500 20 mg in research?
Research protocols typically involve 1000–2000 mcg daily (500–1000 mcg each peptide) via subcutaneous or intramuscular injection, adjusted based on study design. Professional oversight is required.
Are there safety concerns with the BPC-157/TB-500 blend?
Preclinical studies show minimal toxicity, with possible mild injection site reactions. Limited human data necessitates professional supervision for research safety.
How should the BPC-157/TB-500 20 mg vial be stored?
Store the lyophilized powder at -20°C. After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within 30 days to maintain potency.
Related Products
- Active Substance: Thymosin Beta 4 (TB-500) + BPC-157 Pentadecapeptide
- Concentration: 5 mg TB-500 + 5 mg BPC-157 per vial
- Pack Size: 1 vial (lyophilized blend for reconstitution)
- Manufacturer: Dragon Pharma
- Brand Name: Peptide Blend
- Synonyms: BPC-TB Blend, Thymosin Beta-4 + BPC Research Formula, Regenerative Peptide Combo
- Active Substance: Epitalon
- Concentration: 50 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Epitalon
- Molecular Formula: C14H22N4O9
- Molecular Weight: 390.35 g/mol
- Sequence: Ala-Glu-Asp-Gly
- Synonyms: Epithalon, AEDG, Epithalamin analog
- Active Substance: Proxofim (FOXO4-D-Retro-Inverso)
- Concentration: 10 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Proxofim
- Molecular Formula: C228H388N86O64
- Molecular Weight: 5358.05 g/mol
- Sequence: H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH
- Synonyms: Forkhead box protein O4 D-Retro-Inverso, FOXO4a, AFX, AFX1, MLLT7
- Active Substance: HGH Fragment 176-191 (6 mg), Modified GRF (CJC-1295 No DAC, 3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg Modified GRF + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (Modified GRF): C152H252N44O42
- Molecular Weight (Modified GRF): 3367.97 g/mol
- Sequence (Modified GRF): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), Modified GRF (CJC-1295 No DAC), Ipamorelin (GHRP, Ghrelin mimetic)
- Active Substance: HGH Fragment 176-191 (6 mg), CJC1295 No DAC (3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg CJC1295 + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (CJC1295 No DAC): C152H252N44O42
- Molecular Weight (CJC1295 No DAC): 3367.97 g/mol
- Sequence (CJC1295 No DAC): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), CJC1295 No DAC (Mod GRF), Ipamorelin (GHRP, Ghrelin mimetic)